1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
China Cancer Test Market, Volume, Forecast (By Male & Female), Mortality & 26 Cancer (Oncology) Types Market & Volume to 2022

China Cancer Test Market, Volume, Forecast (By Male & Female), Mortality & 26 Cancer (Oncology) Types Market & Volume to 2022

  • August 2017
  • 357 pages
  • ID: 5089258
  • Format: PDF
  • By Renub Research

Summary

Table of Contents

Search Inside

By the end of the year 2022, China Cancer Test Market is expected to cross US$ 24 Billion. China is the leading consumer of tobacco in the worldwide. Urban and Rural areas face high death rate due to the massive impact of growing cancer diseases in China. In order to alleviate cancer prevalence; the government focuses on several Cancer Control Programs which include prevention, early diagnosis and treatment. Early diagnosis programs include screening for breast and cervix cancer while prevention programs such as anti-smoking campaigns and immunization against hepatitis. Public awareness of cancer and the promotion of healthy lifestyle have also been carried out actively.

In this report, we have studied in-depth analysis of 26 types of cancer in which Lung cancer is leading the market because China has high consumer of tobacco in worldwide. China has an exceptional number of lung cancer diagnoses and deaths than any other part of the world. Cancer is one of the most significant public health burdens in China. The problem will keep moving in near future as China’ air pollution goes mostly unchecked.


Lung Cancer leads the China Oncology Market

In China, Lung cancer leads the market in both genders. The report covers the different types of cancers and emphasis on genders. Therefore, the categorization was as follows-

In Male: Lung Cancer is the most predominant cancer and is mainly driven by adult males, half of Chinese men are expected to be current smokers compared to women, followed by Colorectal Cancer, Liver Cancer, Brain, CNS, Esophageal Cancer and Breast Cancer (not in same chorological order).

In Female: Lung cancer cases are less in women as compared to men but other cancers were Liver and Breast Cancer, Uterus and Ovarian Cancer are other most common cancers. Some other Cancers studied in this report are Lip, Oral Cavity, & Pharynx, Nasopharynx, Pancreas, Bone, Prostate, Luekemia, Bladder, Kidney and Lymphoma

Soaring Cancer Mortality Rates

Over the past three decades, Cancer Mortality Rates in China have been rising rapidly. In the urban region, the mortality of cancer is comparatively higher than in rural one. Out of 26 Types of Cancer studied in the report, Lung cancer accounts for the highest fatalities, followed by Digestive Tract Cancers (Stomach, Liver Cancer, Esophageal and Colorectum Cancer).

Renub Research report titled “China Cancer Test Market, Volume, Forecast (By Male & Female), Mortality & 26 Cancer (Oncology) Types Market & Volume to 2022” studies the oncology market in China. This 357 page report with 314 Figures and 12 Tables provides in-depth analysis of China Cancer Tests Market and Volume. All 26 types of cancer in the report have been analyzed from 3 major viewpoints which further study it from 2 different perspectives.

1. China Cancer (Oncology) Screening Tests Market & Forecast
• Male
• Female

2. China Cancer (Oncology) Screening Tests Volume & Forecast
• Male
• Female

3. China Cancer (Oncology) Mortality Rate


All the 26 Cancer Market & Cases Studied in the Report are as Follows:

1. Lip, oral cavity, & pharynx (except nasopharynx)
2. Nasopharynx
3. Esophagus
4. Stomach
5. Colorectum
6. Liver
7. Gallbladder
8. Pancreas
9. Larynx
10. Lung
11. Other thoracic organs
12. Bone
13. Melanoma of the skin
14. Breast
15. Cervix
16. Uterus
17. Ovary
18. Prostate
19. Testis
20. Kidney
21. Bladder
22. Brain, CNS
23. Thyroid
24. Lymphoma
25. Leukemia
26. All other sites and unspecified

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2019

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2019SummaryThis latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2019, provides ...

Prostaglandin E2 Receptor EP4 Subtype - Pipeline Review, H2 2019

Prostaglandin E2 Receptor EP4 Subtype - Pipeline Review, H2 2019

  • $ 3500
  • November 2019

Prostaglandin E2 Receptor EP4 Subtype - Pipeline Review, H2 2019SummaryProstaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) pipeline Target constitutes close to 15 molecules. Out of ...

Chemotherapy Induced Anemia - Pipeline Review, H2 2019

Chemotherapy Induced Anemia - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Chemotherapy Induced Anemia - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Anemia - Pipeline Review, H2 2019, provides an overview ...


ref:plp2017

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on